IRIS Accounts Production v26.2.0.496 12282255 Board of Directors 30.11.25 1.12.24 30.11.25 30.11.25 true true true false true true false false false false false false false false true false Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122822552024-11-30122822552025-11-30122822552024-12-012025-11-30122822552023-11-30122822552023-12-012024-11-30122822552024-11-3012282255ns15:EnglandWales2024-12-012025-11-3012282255ns14:PoundSterling2024-12-012025-11-3012282255ns10:Director12024-12-012025-11-3012282255ns10:Consolidated2025-11-3012282255ns10:ConsolidatedGroupCompanyAccounts2024-12-012025-11-3012282255ns10:PrivateLimitedCompanyLtd2024-12-012025-11-3012282255ns10:Consolidatedns10:FRS1022024-12-012025-11-3012282255ns10:Consolidatedns10:Audited2024-12-012025-11-3012282255ns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2024-12-012025-11-3012282255ns10:LargeMedium-sizedCompaniesRegimeForAccounts2024-12-012025-11-3012282255ns10:Consolidatedns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2024-12-012025-11-3012282255ns10:LargeMedium-sizedCompaniesRegimeForAccountsns10:Consolidated2024-12-012025-11-3012282255ns10:FullAccounts2024-12-012025-11-3012282255ns5:Subsidiary12024-12-012025-11-3012282255ns5:Subsidiary22024-12-012025-11-3012282255ns5:Subsidiary32024-12-012025-11-3012282255ns5:Subsidiary42024-12-012025-11-3012282255ns5:Subsidiary52024-12-012025-11-301228225512024-12-012025-11-3012282255ns10:OrdinaryShareClass12024-12-012025-11-3012282255ns10:Consolidated2024-12-012025-11-3012282255ns10:Director22024-12-012025-11-3012282255ns10:RegisteredOffice2024-12-012025-11-3012282255ns10:Consolidated2023-12-012024-11-3012282255ns5:CurrentFinancialInstruments2025-11-3012282255ns5:CurrentFinancialInstruments2024-11-3012282255ns5:Non-currentFinancialInstruments2025-11-3012282255ns5:Non-currentFinancialInstruments2024-11-3012282255ns5:ShareCapital2025-11-3012282255ns5:ShareCapital2024-11-3012282255ns5:RetainedEarningsAccumulatedLosses2025-11-3012282255ns5:RetainedEarningsAccumulatedLosses2024-11-3012282255ns5:ShareCapital2023-11-3012282255ns5:RetainedEarningsAccumulatedLosses2023-11-3012282255ns5:RetainedEarningsAccumulatedLosses2023-12-012024-11-3012282255ns5:RetainedEarningsAccumulatedLosses2024-12-012025-11-3012282255ns5:NetGoodwill2024-12-012025-11-3012282255ns5:OwnedOrFreeholdAssetsns5:LandBuildings2024-12-012025-11-3012282255ns5:FurnitureFittings2024-12-012025-11-3012282255ns5:MotorVehicles2024-12-012025-11-3012282255ns5:NetGoodwill2024-11-3012282255ns5:NetGoodwill2025-11-3012282255ns5:NetGoodwill2024-11-3012282255ns5:LandBuildings2024-11-3012282255ns5:FurnitureFittings2024-11-3012282255ns5:MotorVehicles2024-11-3012282255ns5:LandBuildings2024-12-012025-11-3012282255ns5:LandBuildings2025-11-3012282255ns5:FurnitureFittings2025-11-3012282255ns5:MotorVehicles2025-11-3012282255ns5:LandBuildings2024-11-3012282255ns5:FurnitureFittings2024-11-3012282255ns5:MotorVehicles2024-11-3012282255ns5:CostValuation2024-11-3012282255ns5:Subsidiary112024-12-012025-11-30122822553ns5:Subsidiary22024-12-012025-11-3012282255ns5:Subsidiary352024-12-012025-11-30122822557ns5:Subsidiary42024-12-012025-11-30122822559ns5:Subsidiary52024-12-012025-11-3012282255ns5:CurrentFinancialInstrumentsns5:WithinOneYear2025-11-3012282255ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-11-3012282255ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-11-3012282255ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-11-3012282255ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-11-3012282255ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-11-3012282255ns5:DeferredTaxation2024-11-3012282255ns5:DeferredTaxation2024-12-012025-11-3012282255ns5:DeferredTaxation2025-11-3012282255ns10:OrdinaryShareClass12025-11-3012282255ns5:RetainedEarningsAccumulatedLosses2024-11-30
REGISTERED NUMBER: 12282255 (England and Wales)















Group Strategic Report, Report of the Directors and

Consolidated Financial Statements for the Year Ended 30 November 2025

for

LP Healthcare Limited

LP Healthcare Limited (Registered number: 12282255)






Contents of the Consolidated Financial Statements
for the Year Ended 30 November 2025




Page

Company Information 1

Group Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 4

Consolidated Income Statement 7

Consolidated Other Comprehensive Income 8

Consolidated Balance Sheet 9

Company Balance Sheet 10

Consolidated Statement of Changes in Equity 11

Company Statement of Changes in Equity 12

Consolidated Cash Flow Statement 13

Notes to the Consolidated Cash Flow Statement 14

Notes to the Consolidated Financial Statements 15


LP Healthcare Limited

Company Information
for the Year Ended 30 November 2025







DIRECTORS: Mrs K L Rogerson
Mr P J Rogerson





REGISTERED OFFICE: 19 Park Street
Lytham
Lancashire
FY85LU





REGISTERED NUMBER: 12282255 (England and Wales)





AUDITORS: Ashworth Treasure Limited
Statutory Auditors
17-19 Park Street
Lytham
Lancashire
FY8 5LU

LP Healthcare Limited (Registered number: 12282255)

Group Strategic Report
for the Year Ended 30 November 2025

The directors present their strategic report of the company and the group for the year ended 30 November 2025.

REVIEW OF BUSINESS
The directors are satisfied with the results for the year and continue to pursue a growth strategy that combines organic expansion with acquisitions of existing homes. The company continues to invest in the maintenance and enhancement of existing homes.

Key performance indicators
Turnover and profits
Group turnover has increased by 14% to £7,274,646 and profits before tax increased from £722,972 to £1,192,755 with the group maintaining strong cash reserves at the end of the year.

Gross profit for the year was £3,478,666 (2024: £2,968,803) an increase of 17% year-on-year.

The profit after taxation for the year amounted to £742,291 (2024: £446,928).

Borrowing and liquidity
Borrowing increased in the year from £5,934,171 in 2024 to £6,795,042 in 2025 in order to finance the extension of a nursing home. The liquidity ratio improved from 206% in 2024 to 303% in 2025.

Occupancy
Target occupancy levels are 95%. The average levels achieved in 2025 were 94% (2024: 95%).

PRINCIPAL RISKS AND UNCERTAINTIES
The principle risk for the business would be a poor report from its regulators, this risk is mitigated by the groups commitment to the provision of exceptional care in each home it operates with constant monitoring and investment in employee training.

Financial operating risks to the business in recent and future years continue to be rising staff costs due to minimum wages increases and agency reliance because of workforce availability. Also, dependence on local authority or NHS funding which may be constrained and risk of changes in government funding models or fee caps. These are monitored with good budgeting, staff rota management and payment policies.

Rising costs due to inflation,especially in energy, food, wages and lending interest rates all pose a risk to the profitability and repayment of debt.

The group is well placed and maintains a strategy of strong management and leadership which enable the companies to react quickly to any future risks or uncertainties.

FUTURE DEVELOPMENTS
The directors remain committed to providing high-quality residential and nursing care across all its facilities. In the coming year, the group plans to undertake a programme of investment in its properties including an extension at one of the homes in order to increase occupancy levels.

Recruitment and retention of skilled care staff remains a priority. The group will expand its in-house training programmes and continue to invest in staff to address sector-wide workforce challenges.

ON BEHALF OF THE BOARD:





Mrs K L Rogerson - Director


26 August 2026

LP Healthcare Limited (Registered number: 12282255)

Report of the Directors
for the Year Ended 30 November 2025

The directors present their report with the financial statements of the company and the group for the year ended 30 November 2025.

PRINCIPAL ACTIVITY
The principal activity of the group in the year under review was that of the running of residential care homes.

DIVIDENDS
An interim dividend of £330 per share was paid on 23 July 2025. The directors recommend that no final dividend be paid.

The total distribution of dividends for the year ended 30 November 2025 will be £ 330,000 .

DIRECTORS
The directors shown below have held office during the whole of the period from 1 December 2024 to the date of this report.

Mrs K L Rogerson
Mr P J Rogerson

DISCLOSURE IN THE STRATEGIC REPORT
The strategic report on the preceding page provides information regarding the performance, developments, and risks and uncertainties of the group.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Group Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

AUDITORS
The auditors, Ashworth Treasure Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





Mrs K L Rogerson - Director


26 August 2026

Report of the Independent Auditors to the Members of
LP Healthcare Limited

Opinion
We have audited the financial statements of LP Healthcare Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 30 November 2025 which comprise the Consolidated Income Statement, Consolidated Other Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the group's and of the parent company affairs as at 30 November 2025 and of the group's profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Report of the Independent Auditors to the Members of
LP Healthcare Limited


Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:
- the engagement partner ensured that the engagement team collectively had the appropriate competence,
capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
- we identified the laws and regulations applicable to the group through discussions with directors and other
management, and from our commercial knowledge and experience of the business sector;
- we focused on specific laws and regulations which we considered may have a direct material effect on the
financial statements or the operations of the group, including legislation such as Companies Act, taxation
legislation, environmental and health and safety legislation etc.
- we assessed the extent of compliance with the laws and regulations identified above through making enquiries
of management and inspecting legal correspondence; and
- identified laws and regulations were communicated within the audit team regularly and the team maintained alert
to instances of non-compliance throughout the audit.

We assessed the susceptibility of the group's financial statements to misstatement, including obtaining an understanding of how fraud might occur, by:
- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge
of actual, suspected and alleged fraud;and
- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:
- performed analytical procedures to identify any unusual or unexpected relationships;
- tested journals to identify unusual transactions;
- assessed whether judgements and assumptions made in determining the accounting estimates were indicative
of potential bias; and
- investigated the rationale behind significant or unusual transactions.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
- agreeing financial statement disclosures to underlying supporting documentation;
- enquiring of management as to actual and potential litigation and claims;
- reviewing correspondence with HMRC etc

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
LP Healthcare Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Victoria Reynolds (Senior Statutory Auditor)
for and on behalf of Ashworth Treasure Limited
Statutory Auditors
17-19 Park Street
Lytham
Lancashire
FY8 5LU

26 August 2026

LP Healthcare Limited (Registered number: 12282255)

Consolidated Income Statement
for the Year Ended 30 November 2025

2025 2024
Notes £    £   

TURNOVER 7,274,646 6,369,632

Cost of sales 3,795,980 3,400,829
GROSS PROFIT 3,478,666 2,968,803

Administrative expenses 1,768,668 1,777,556
1,709,998 1,191,247

Other operating income - 333
OPERATING PROFIT 6 1,709,998 1,191,580

Interest receivable and similar income 14,489 8,871
1,724,487 1,200,451

Interest payable and similar expenses 7 531,732 477,479
PROFIT BEFORE TAXATION 1,192,755 722,972

Tax on profit 8 450,464 276,044
PROFIT FOR THE FINANCIAL YEAR 742,291 446,928
Profit attributable to:
Owners of the parent 742,291 446,928

LP Healthcare Limited (Registered number: 12282255)

Consolidated Other Comprehensive Income
for the Year Ended 30 November 2025

2025 2024
Notes £    £   

PROFIT FOR THE YEAR 742,291 446,928


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR
THE YEAR

742,291

446,928

Total comprehensive income attributable to:
Owners of the parent 742,291 446,928

LP Healthcare Limited (Registered number: 12282255)

Consolidated Balance Sheet
30 November 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 11 1,133,810 1,579,928
Tangible assets 12 5,351,488 4,693,932
Investments 13 - -
6,485,298 6,273,860

CURRENT ASSETS
Stocks 14 5,455 6,850
Debtors 15 1,002,691 709,243
Cash at bank 2,120,488 1,208,772
3,128,634 1,924,865
CREDITORS
Amounts falling due within one year 16 1,033,758 932,889
NET CURRENT ASSETS 2,094,876 991,976
TOTAL ASSETS LESS CURRENT
LIABILITIES

8,580,174

7,265,836

CREDITORS
Amounts falling due after more than one
year

17

(6,679,876

)

(5,826,228

)

PROVISIONS FOR LIABILITIES 20 (387,044 ) (338,645 )
NET ASSETS 1,513,254 1,100,963

CAPITAL AND RESERVES
Called up share capital 21 100 100
Retained earnings 22 1,513,154 1,100,863
SHAREHOLDERS' FUNDS 1,513,254 1,100,963

The financial statements were approved by the Board of Directors and authorised for issue on 26 August 2026 and were signed on its behalf by:





Mrs K L Rogerson - Director


LP Healthcare Limited (Registered number: 12282255)

Company Balance Sheet
30 November 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 11 1,133,810 1,579,928
Tangible assets 12 4,850,994 4,197,199
Investments 13 500 500
5,985,304 5,777,627

CURRENT ASSETS
Debtors 15 1,256,996 1,064,018
Cash at bank 486,494 111,905
1,743,490 1,175,923
CREDITORS
Amounts falling due within one year 16 605,678 792,067
NET CURRENT ASSETS 1,137,812 383,856
TOTAL ASSETS LESS CURRENT
LIABILITIES

7,123,116

6,161,483

CREDITORS
Amounts falling due after more than one
year

17

(6,679,876

)

(5,817,061

)

PROVISIONS FOR LIABILITIES 20 (266,350 ) (219,382 )
NET ASSETS 176,890 125,040

CAPITAL AND RESERVES
Called up share capital 21 100 100
Retained earnings 22 176,790 124,940
SHAREHOLDERS' FUNDS 176,890 125,040

Company's profit for the financial year 381,850 409,522

The financial statements were approved by the Board of Directors and authorised for issue on 26 August 2026 and were signed on its behalf by:





Mrs K L Rogerson - Director


LP Healthcare Limited (Registered number: 12282255)

Consolidated Statement of Changes in Equity
for the Year Ended 30 November 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 December 2023 100 944,935 945,035

Changes in equity
Dividends - (291,000 ) (291,000 )
Total comprehensive income - 446,928 446,928
Balance at 30 November 2024 100 1,100,863 1,100,963

Changes in equity
Dividends - (330,000 ) (330,000 )
Total comprehensive income - 742,291 742,291
Balance at 30 November 2025 100 1,513,154 1,513,254

LP Healthcare Limited (Registered number: 12282255)

Company Statement of Changes in Equity
for the Year Ended 30 November 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 December 2023 100 6,418 6,518

Changes in equity
Dividends - (291,000 ) (291,000 )
Total comprehensive income - 409,522 409,522
Balance at 30 November 2024 100 124,940 125,040

Changes in equity
Dividends - (330,000 ) (330,000 )
Total comprehensive income - 381,850 381,850
Balance at 30 November 2025 100 176,790 176,890

LP Healthcare Limited (Registered number: 12282255)

Consolidated Cash Flow Statement
for the Year Ended 30 November 2025

2025 2024
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,834,904 1,269,846
Interest paid (531,732 ) (477,479 )
Tax paid (209,276 ) (338,809 )
Net cash from operating activities 1,093,896 453,558

Cash flows from investing activities
Purchase of intangible fixed assets - (1,454,998 )
Purchase of tangible fixed assets (800,451 ) (1,366,044 )
Interest received 14,489 8,871
Net cash from investing activities (785,962 ) (2,812,171 )

Cash flows from financing activities
New loans in year 1,000,000 4,328,468
Loan repayments in year (103,233 ) (1,390,512 )
Amount withdrawn by directors (292,985 ) (329,056 )
Net cash from financing activities 603,782 2,608,900

Increase in cash and cash equivalents 911,716 250,287
Cash and cash equivalents at beginning
of year

2

1,208,772

958,485

Cash and cash equivalents at end of year 2 2,120,488 1,208,772

LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Cash Flow Statement
for the Year Ended 30 November 2025

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2025 2024
£    £   
Profit before taxation 1,192,755 722,972
Depreciation charges 589,013 473,133
Finance costs 531,732 477,479
Finance income (14,489 ) (8,871 )
2,299,011 1,664,713
Decrease/(increase) in stocks 1,395 (2,450 )
Increase in trade and other debtors (330,463 ) (114,204 )
Decrease in trade and other creditors (135,039 ) (278,213 )
Cash generated from operations 1,834,904 1,269,846

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 30 November 2025
30.11.25 1.12.24
£    £   
Cash and cash equivalents 2,120,488 1,208,772
Year ended 30 November 2024
30.11.24 1.12.23
£    £   
Cash and cash equivalents 1,208,772 958,485


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.12.24 Cash flow At 30.11.25
£    £    £   
Net cash
Cash at bank 1,208,772 911,716 2,120,488
1,208,772 911,716 2,120,488
Debt
Debts falling due within 1 year (113,714 ) (1,452 ) (115,166 )
Debts falling due after 1 year (5,784,561 ) (895,315 ) (6,679,876 )
(5,898,275 ) (896,767 ) (6,795,042 )
Total (4,689,503 ) 14,949 (4,674,554 )

LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements
for the Year Ended 30 November 2025

1. STATUTORY INFORMATION

LP Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Basis of consolidation
The group financial statements consolidate the accounts of LP Healthcare Limited and its subsidiary undertakings, Abbotsfield Care Home Limited, Greenlane (Cumbria) Limited, Croft Avenue Care Home Limited, Inglewood (Cumbria) Limited and The Ferns Care Home Limited.

Unless otherwise stated, the acquisition method of accounting has been adopted. Under this method, the results of subsidiary undertakings acquired or disposed of in the year are included in the consolidated profit and loss account from the date on which control passed.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is derived from residents fees either private or local authority and is recognised in line with the date of stay. Any amounts paid for in advance are deferred on the balance sheet and any stays not yet paid for are accrued accordingly.

Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business.

Goodwill was paid in connection with the purchase of businesses in 2020, 2021 and 2024.

Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed five years.

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that assets as follows:

Goodwill - straight line basis over 5 years

If there is an indication that there has been significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 30 November 2025

3. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Freehold property - 2% cost of buildings, 0% cost of land
Fixtures, fittings and equipment - 10% on reducing balance
Motor vehicles - 25% on reducing balance

Freehold land and buildings and fixtures, fittings and equipment are stated at cost less depreciation over expected useful lives. Cost represents purchase price together with any incidental costs of acquisition.

Investments in subsidiaries
Investments in subsidiaries are recognised at cost. Dividends and other distributions received from the investment are recognised as income.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The following assets and liabilities are classified as financial instruments - investments in subsidiaries, trade debtors, trade creditors, bank loans, other loans and inter-group balances.

Investments in subsidiary undertakings are measured at cost less impairment.

Bank loans are initially measured at the present value of future payments, discounted at a market rate of interest, and subsequently at amortised cost using the effective interest method.

Inter-group balances (being repayable on demand), trade debtors, trade creditors and other loans are measured at the undiscounted amount of cash or other consideration expected to be paid or received.

Financial assets are assessed at the end of each reporting period for objective evidence of impairment and if applicable recognised as appropriate.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 30 November 2025

3. ACCOUNTING POLICIES - continued

Subsidiary exemption from audit by parent guarantee
The following subsidiaries included in these consolidated accounts are exempt from the relevant audit requirements of the Companies Act by virtue of S479A:
Croft Avenue Care Home Limited 13565869 (England and Wales)
Inglewood (Cumbria) Limited 13273566 (England and Wales)
Abbotsfield Care Home Limited 12282796 (England and Wales)
Greenlane (Cumbria) Limited 12326226 (England and Wales)
The Ferns Care Home Limited 15117795 (England and Wales)


4. ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

In the application of the company's accounting policies, management is required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily available from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both.

The sources of judgment uncertainty that have a significant effect on the amounts recognised in the financial statements are described below:

Impairment of non-financial assets
Non-financial assets include goodwill, investments and tangible fixed assets. The company assesses at each reporting date whether there is an indication that the carrying amount of an asset may not be recoverable. If there is such an indication then the company estimates the recoverable amount of the asset using the information available at that date. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. If the recoverable amount is less than the carrying amount, the carrying amount of an asset is impaired and it is reduced to its recoverable amount through an impairment in the statement of comprehensive income.

5. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 3,381,363 3,056,071
Social security costs 330,570 237,743
Other pension costs 59,031 53,060
3,770,964 3,346,874

The average number of employees during the year was as follows:
2025 2024

Office and managers 9 11
Nurses and carers 106 103
Cleaning, maintenance and catering 34 40
149 154

2025 2024
£    £   
Directors' remuneration 187,824 159,565

LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 30 November 2025

6. OPERATING PROFIT

The operating profit is stated after charging:

2025 2024
£    £   
Depreciation - owned assets 142,895 138,008
Goodwill amortisation 446,118 335,125
Auditors' remuneration 24,000 30,000
Auditors' remuneration for non audit work 24,871 28,019

7. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Bank interest - 46
Bank loan interest 531,278 477,365
Other interest 454 68
531,732 477,479

8. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 402,065 221,247

Deferred tax 48,399 54,797
Tax on profit 450,464 276,044

UK corporation tax has been charged at 25 % (2024 - 25 %).

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Profit before tax 1,192,755 722,972
Profit multiplied by the standard rate of corporation tax in the UK of 25 %
(2024 - 25 %)

298,189

180,743

Effects of:
Expenses not deductible for tax purposes 2,466 505
Capital allowances in excess of depreciation (10,119 ) (43,782 )
Amortisation on non qualifying assets 111,529 83,781
Other timing differences 48,399 54,797
Total tax charge 450,464 276,044

9. INDIVIDUAL INCOME STATEMENT

As permitted by Section 408 of the Companies Act 2006, the Income Statement of the parent company is not presented as part of these financial statements.


LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 30 November 2025

10. DIVIDENDS
2025 2024
£    £   
Ordinary shares of 1 each
Interim 330,000 291,000

11. INTANGIBLE FIXED ASSETS

Group
Goodwill
£   
COST
At 1 December 2024
and 30 November 2025 2,584,998
AMORTISATION
At 1 December 2024 1,005,070
Amortisation for year 446,118
At 30 November 2025 1,451,188
NET BOOK VALUE
At 30 November 2025 1,133,810
At 30 November 2024 1,579,928

Company
Goodwill
£   
COST
At 1 December 2024
and 30 November 2025 2,584,998
AMORTISATION
At 1 December 2024 1,005,070
Amortisation for year 446,118
At 30 November 2025 1,451,188
NET BOOK VALUE
At 30 November 2025 1,133,810
At 30 November 2024 1,579,928

LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 30 November 2025

12. TANGIBLE FIXED ASSETS

Group
Fixtures,
fittings
Freehold and Motor
property equipment vehicles Totals
£    £    £    £   
COST
At 1 December 2024 3,998,588 1,089,632 - 5,088,220
Additions 737,647 58,807 3,997 800,451
At 30 November 2025 4,736,235 1,148,439 3,997 5,888,671
DEPRECIATION
At 1 December 2024 137,983 256,305 - 394,288
Charge for year 53,940 88,705 250 142,895
At 30 November 2025 191,923 345,010 250 537,183
NET BOOK VALUE
At 30 November 2025 4,544,312 803,429 3,747 5,351,488
At 30 November 2024 3,860,605 833,327 - 4,693,932

Company
Fixtures,
fittings
Freehold and Motor
property equipment vehicles Totals
£    £    £    £   
COST
At 1 December 2024 3,998,588 460,001 - 4,458,589
Additions 737,647 - 3,997 741,644
At 30 November 2025 4,736,235 460,001 3,997 5,200,233
DEPRECIATION
At 1 December 2024 137,983 123,407 - 261,390
Charge for year 53,940 33,659 250 87,849
At 30 November 2025 191,923 157,066 250 349,239
NET BOOK VALUE
At 30 November 2025 4,544,312 302,935 3,747 4,850,994
At 30 November 2024 3,860,605 336,594 - 4,197,199

13. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 December 2024
and 30 November 2025 500
NET BOOK VALUE
At 30 November 2025 500
At 30 November 2024 500

LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 30 November 2025

13. FIXED ASSET INVESTMENTS - continued

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiaries

Abbotsfield Care Home Limited
Registered office: 19 Park Street, Lytham, Lancashire, FY8 5LU
Nature of business: Residential nursing home
%
Class of shares: holding
Ordinary 100.00

Greenlane (Cumbria) Limited
Registered office: 19 Park Street, Lytham, Lancashire, FY8 5LU
Nature of business: Residential nursing home
%
Class of shares: holding
Ordinary 100.00

The Ferns Care Home Limited
Registered office: 19 Park Street, Lytham, Lancashire FY8 5LU
Nature of business: Residential nursing home
%
Class of shares: holding
Ordinary 100.00

Inglewood (Cumbria) Limited
Registered office: 19 Park Street, Lytham, Lancashire, FY8 5LU
Nature of business: Residential nursing home
%
Class of shares: holding
Ordinary 100.00

Croft Avenue Care Home Limited
Registered office: 19 Park Street, Lytham, Lancashire, FY8 5LU
Nature of business: Residential nursing home
%
Class of shares: holding
Ordinary 100.00


14. STOCKS

Group
2025 2024
£    £   
Stocks 5,455 6,850

15. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Trade debtors 58,244 48,407 - -
Amounts owed by group undertakings - - 940,486 701,933
Other debtors 594,518 257,493 1,635 1,635
Directors' loan accounts 291,162 328,177 291,162 328,177
Prepayments and accrued income 58,767 75,166 23,713 32,273
1,002,691 709,243 1,256,996 1,064,018

LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 30 November 2025

16. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans and overdrafts (see note 18) 115,166 113,714 105,999 103,714
Trade creditors 138,748 194,063 10,292 -
Amounts owed to group undertakings - - 138,592 349,584
Tax 327,093 134,304 - -
Social security and other taxes 404 404 - -
Other creditors 48,696 83,886 293,436 268,095
Accruals and deferred income 403,651 406,518 57,359 70,674
1,033,758 932,889 605,678 792,067

17. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans (see note 18) 6,679,876 5,784,561 6,679,876 5,775,394
Other creditors - 41,667 - 41,667
6,679,876 5,826,228 6,679,876 5,817,061

18. LOANS

An analysis of the maturity of loans is given below:

Group Company
2025 2024 2025 2024
£    £    £    £   
Amounts falling due within one year or on demand:
Bank loans 115,166 113,714 105,999 103,714
Amounts falling due between one and two years:
Bank loans - 1-2 years 2,565,097 120,110 2,565,097 110,943
Amounts falling due between two and five years:
Bank loans - 2-5 years 4,114,779 5,664,451 4,114,779 5,664,451

19. SECURED DEBTS

The following secured debts are included within creditors:

Group Company
2025 2024 2025 2024
£    £    £    £   
Bank loans 6,795,042 5,934,171 6,785,786 5,934,171

The bank loans are secured by fixed and floating charges over the group's properties and assets, together with debentures over all assets, cross guarantees with subsidiary companies and a personal guarantee from the directors.

LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 30 November 2025

20. PROVISIONS FOR LIABILITIES

Group Company
2025 2024 2025 2024
£    £    £    £   
Deferred tax 387,044 338,645 266,350 219,382

Group
Deferred
tax
£   
Balance at 1 December 2024 338,645
Provided during year 48,399
Balance at 30 November 2025 387,044

Company
Deferred
tax
£   
Balance at 1 December 2024 219,382
Provided during year 46,968
Balance at 30 November 2025 266,350

The deferred tax provision for both the group and the company arises solely as a result of capital allowances in excess of depreciation.

21. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
100 Ordinary 1 100 100

22. RESERVES

Group
Retained
earnings
£   

At 1 December 2024 1,100,863
Profit for the year 742,291
Dividends (330,000 )
At 30 November 2025 1,513,154

Company
Retained
earnings
£   

At 1 December 2024 124,940
Profit for the year 381,850
Dividends (330,000 )
At 30 November 2025 176,790


LP Healthcare Limited (Registered number: 12282255)

Notes to the Consolidated Financial Statements - continued
for the Year Ended 30 November 2025

23. CAPITAL COMMITMENTS

The group has spent £610,000 in the year building an extension to one of its existing homes which it is committed to complete. The total expected cost of the extension is £1.2m. A bank loan was taken out in the year to cover this cost.

24. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 November 2025 and 30 November 2024:

2025 2024
£    £   
Mrs K L Rogerson and Mr P J Rogerson
Balance outstanding at start of year 328,177 290,121
Amounts advanced 292,985 329,056
Amounts repaid (330,000 ) (291,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 291,162 328,177

Interest was charged at the official rate of interest where appropriate.

The directors of the company have provided a personal guarantee in respect of a bank loan facility amounting to £550,000. No amounts have been paid in respect of this guarantee.

25. RELATED PARTY DISCLOSURES

Entities with control, joint control or significant influence over the entity

Included in debtors at 30 November 2025 are the following net amounts owed to the group by companies related by virtue of common control:

Kingsfield (Cumbria) Limited £64,805 (2024: £23,494).
P H Care Limited £471,774 (2024: £223,273).
Knowle Care Home Limited £52,042 (2024 creditor: £32,364).
Stanfield Nursing Home Limited £2,271 (2024: £0).

All related party loans are interest free, unsecured and repayable on demand.

The group's key management personel are considered to be the directors. Their compensation during the year is shown in note 5.

26. ULTIMATE CONTROLLING PARTY

There is no ultimate controlling party.